Drug Repurposing Pipeline
SkillDev toolsSystematic drug repurposing analysis inspired by NovusAI. Evaluates existing drugs for new therapeutic indications through multi-dimensional evidence gathering across target networks, clinical trials (including failures), patent landscape, safety profiles, and off-label literature. Produces ranked repurposing candidates with evidence scores. Use when users ask about finding new uses for existing drugs, off-label potential, "老药新用", or "drug repurposing for X". Complements target-validation (which starts from a target) by starting from a drug.
Available today. Use it from your connected AI after setup.
No other account needed.
Connect ahel once, and every AI you use reads what you have installed.
Then ask your AI: use the Drug Repurposing Pipeline skill
What this skill tells your AI
The instructions your AI receives, as published by zaoqu-liu/scienceclaw in skills/drug-repurposing/SKILL.md and read by ahel’s review.
Systematically evaluate an existing drug for new therapeutic indications by mining evidence across six dimensions: pharmacology, target networks, clinical trials, literature, patents, and safety.
When to Use
- "帮我找 metformin 的新适应症"
- "Sorafenib 除了肝癌还能治什么"
- "Drug repurposing opportunities for thalidomide"
- "X 的老药新用潜力"
- Any query about finding new uses for existing drugs
Pipeline
Step 1: Drug Profile
Gather comprehensive drug information:
bash: echo "=== DrugBank ===" && \
curl -s "https://go.drugbank.com/unearth/q?searcher=drugs&query=DRUGNAME&button=" 2>/dev/null && \
echo -e "\n=== ChEMBL ===" && \
curl -s "https://www.ebi.ac.uk/chembl/api/data/molecule/search.json?q=DRUGNAME&limit=5" && \
echo -e "\n=== PubChem ===" && \
curl -s "https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/DRUGNAME/JSON"
Extract:
- Approved indications and year of first approval
- Primary mechanism of action
- Known molecular targets (with confidence)
- Chemical class and properties (MW, logP, PSA)
- Half-life, bioavailability, metabolism pathway (CYP enzymes)
Step 2: Target Network Analysis
Map drug targets to disease associations:
bash: echo "=== STRING PPI Network ===" && \
curl -s "https://string-db.org/api/json/network?identifiers=TARGET_GENE&species=9606&required_score=700" && \
echo -e "\n=== OpenTargets Disease Associations ===" && \
curl -s -X POST "https://api.platform.opentargets.org/api/v4/graphql" \
-H "Content-Type: application/json" \
-d '{"query":"{ target(ensemblId:\"ENSG_ID\") { id approvedSymbol associatedDiseases(page:{size:20}) { rows { disease { id name } score datatypeScores { componentId score } } } } }"}'
Key analysis:
- Primary targets → known diseases (already approved)
- Secondary/off-targets → new disease candidates
- PPI network neighbors → diseases associated with interacting proteins
- Pathway enrichment → which disease pathways are modulated
Step 3: Clinical Evidence Mining
Search for ALL clinical activity of this drug, including off-label and failed trials:
bash: echo "=== ClinicalTrials.gov (all indications) ===" && \
curl -s "https://clinicaltrials.gov/api/v2/studies?query.term=DRUGNAME&pageSize=50&sort=LastUpdatePostDate:desc" && \
echo -e "\n=== PubMed (off-label + repurposing) ===" && \
curl -s "https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&retmode=json&retmax=30&sort=relevance&term=DRUGNAME+AND+(repurpos*+OR+off-label+OR+repositioning+OR+novel+indication+OR+unexpected+effect)"
What to look for:
- Trials in non-approved indications (especially Phase 2+ with positive signals)
- Failed trials that revealed unexpected beneficial effects
- Case reports of off-label use with documented outcomes
- Systematic reviews of repurposing evidence
Step 4: Patent Landscape
bash: web_search "DRUGNAME patent expiry date generic availability"
Assess:
- Patent status: Active / Expired / Expiring soon
- Generic availability: Already available = lower barrier to repurposing
- New formulation patents: May protect specific delivery methods
- Method-of-use patents: Filed for new indications?
Patent scoring:
- Expired + generic available: 20/20 (immediate repurposing potential)
- Expiring within 3 years: 15/20
- Active but no method-of-use patent for new indication: 10/20
- Active with broad claims: 5/20
Step 5: Safety Profile
bash: echo "=== OpenFDA Adverse Events ===" && \
curl -s "https://api.fda.gov/drug/event.json?search=patient.drug.openfda.generic_name:%22DRUGNAME%22&count=patient.reaction.reactionmeddrapt.exact&limit=20" && \
echo -e "\n=== PubMed Safety ===" && \
curl -s "https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&retmode=json&retmax=10&term=DRUGNAME+AND+(safety+OR+adverse+OR+toxicity)+AND+review"
Dual-use signal detection: Some adverse effects hint at therapeutic potential:
| Adverse Effect | Potential Therapeutic Use |
|---|---|
| Weight loss | Obesity / metabolic syndrome |
| Hypoglycemia | Type 2 diabetes (if not already indicated) |
| Immunosuppression | Autoimmune diseases |
| Anti-proliferative effects | Cancer |
| Sedation | Insomnia / anxiety |
| Hair growth | Alopecia |
Flag these "adverse effects as therapeutic signals" prominently.
Step 6: Repurposing Candidate Ranking
Score each candidate indication across four dimensions:
| Dimension | Max Score | Criteria |
|---|---|---|
| Target evidence | 30 | Direct target involvement in disease (OpenTargets score, genetic evidence, expression data) |
| Clinical evidence | 30 | Positive trials, case reports, off-label efficacy data |
| Safety | 20 | Known safety profile compatible with chronic use; no organ-specific toxicity conflict |
| Patent/feasibility | 20 | Patent expired, generic available, regulatory pathway clear |
Total score interpretation:
- ≥70: Strong candidate — proceed to clinical validation planning
- 50–69: Moderate candidate — needs more preclinical evidence
- 30–49: Weak candidate — interesting signal but insufficient evidence
- <30: Not recommended — speculative at best
Output Report Structure
# Drug Repurposing Analysis: [DRUGNAME]
## Executive Summary
- [Drug] is approved for [indication] since [year]
- Analysis identified [N] potential repurposing candidates
- Top candidate: [Disease] (score: XX/100, evidence: ...)
## 1. Drug Profile
[Mechanism, targets, pharmacology]
## 2. Target Network & New Disease Associations
[Network figure + disease mapping table]
## 3. Clinical Evidence
[Trial summaries, off-label reports, case studies]
## 4. Patent Landscape
[Patent status, generic availability, IP barriers]
## 5. Safety Profile
[AE summary + dual-use signal analysis]
## 6. Ranked Repurposing Candidates
| Rank | Indication | Target Evidence | Clinical Evidence | Safety | Patent | Total | Verdict |
|------|-----------|----------------|-------------------|--------|--------|-------|---------|
| 1 | [Disease A] | 25/30 | 20/30 | 18/20 | 20/20 | 83/100 | Strong |
| 2 | [Disease B] | 20/30 | 15/30 | 15/20 | 15/20 | 65/100 | Moderate |
| ... | ... | ... | ... | ... | ... | ... | ... |
## 7. Recommended Next Steps
[For each strong candidate: specific preclinical/clinical validation steps]
## References
[GB/T 7714 format]
Follow-up Suggestions
After completing the repurposing analysis, suggest:
- For the top candidate: "可以用 gene-landscape recipe 深入分析 [target] 在 [new disease] 中的角色"
- If clinical trials exist: "可以用 clinical-query recipe 详细了解 [new disease] 的现有治疗方案,评估竞争格局"
- If target validation needed: "可以用 target-validation recipe 全面评估 [target] 的成药性"
Signals
- GitHub stars
- 60
- Forks
- 14
- Last commit
- Mar 2026
Advanced
- Catalog kind
- skill
- Gateway key
drug-repurposing-zaoqu-liu- Source
- github.com/zaoqu-liu/scienceclaw